Skip to main content
Top
Published in: Abdominal Radiology 1/2015

01-01-2015

Differentiation of poorly differentiated colorectal adenocarcinomas from well- or moderately differentiated colorectal adenocarcinomas at contrast-enhanced multidetector CT

Authors: Ji Eun Kim, Jeong Min Lee, Jee Hyun Baek, Sung Kyung Moon, Se Hyung Kim, Joon Koo Han, Byung Ihn Choi

Published in: Abdominal Radiology | Issue 1/2015

Login to get access

Abstract

Purpose

The purpose of the study is to describe the CT findings of poorly differentiated (PD) colorectal adenocarcinoma (CRAC) compared with those of well- (WD) or moderately differentiated (MD) CRAC.

Materials and methods

One hundred and thirteen patients with pathologically proven PD (n = 26), WD (n = 35), or MD (n = 52) CRACs and who had undergone preoperative, contrast-enhanced multidetector CT (MDCT) imaging were included. Analysis of the CT findings included the morphologic and enhancement features of primary tumors and regional lymph nodes (LNs), and the presence of direct invasion, colonic obstruction, and distant metastasis. The significance of these findings was determined using the χ 2 test.

Results

Significant features favoring the diagnosis of PD CRACs over WD or MD CRACs included their bulky shape, heterogeneous enhancement, iso- or hypoattenuation compared with that of muscle, nodular pericolic fat infiltration, regional LNs > 10 mm, and/or with iso- or hypoattenuation compared with that of muscle, and the presence of distant metastasis (P < 0.05). When at least two of these seven imaging features were used in combination, the sensitivity and specificity in the diagnosis of PD CRACs were 88% and 70%, respectively.

Conclusion

Using characteristic CT features, one can differentiate PD CRAC from WD or MD CRAC with a high degree of accuracy on contrast-enhanced MDCT.
Literature
1.
2.
go back to reference Horton KM, Abrams RA, Fishman EK (2000) Spiral CT of colon cancer: imaging features and role in management. Radiographics 20:419–430PubMedCrossRef Horton KM, Abrams RA, Fishman EK (2000) Spiral CT of colon cancer: imaging features and role in management. Radiographics 20:419–430PubMedCrossRef
3.
go back to reference Kaur H, Choi H, You YN, et al. (2012) MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics 32:389–409PubMedCrossRef Kaur H, Choi H, You YN, et al. (2012) MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics 32:389–409PubMedCrossRef
4.
go back to reference Takeuchi K, Kuwano H, Tsuzuki Y, et al. (2004) Linicopathological characteristics of poorly differentiated adenocarcinoma of the colon and rectum. Hepatogastroenterology 51:1698–1702PubMed Takeuchi K, Kuwano H, Tsuzuki Y, et al. (2004) Linicopathological characteristics of poorly differentiated adenocarcinoma of the colon and rectum. Hepatogastroenterology 51:1698–1702PubMed
5.
go back to reference Kazama Y, Watanabe T, Kanazawa T, et al. (2008) Poorly differentiated colorectal adenocarcinomas show higher rates of microsatellite instability and promoter methylation of p16 and hMLH1: a study matched for T classification and tumor location. J Surg Oncol 97:278–283PubMedCrossRef Kazama Y, Watanabe T, Kanazawa T, et al. (2008) Poorly differentiated colorectal adenocarcinomas show higher rates of microsatellite instability and promoter methylation of p16 and hMLH1: a study matched for T classification and tumor location. J Surg Oncol 97:278–283PubMedCrossRef
6.
go back to reference Chung CK, Zaino RJ, Stryker JA (1982) Colorectal carcinoma: evaluation of histologic grade and factors influencing prognosis. J Surg Oncol 21:143–148PubMedCrossRef Chung CK, Zaino RJ, Stryker JA (1982) Colorectal carcinoma: evaluation of histologic grade and factors influencing prognosis. J Surg Oncol 21:143–148PubMedCrossRef
7.
go back to reference Jass JR (1988) The pathological grading and staging of rectal cancer. Scand J Gastroenterol Suppl 149:21–38PubMedCrossRef Jass JR (1988) The pathological grading and staging of rectal cancer. Scand J Gastroenterol Suppl 149:21–38PubMedCrossRef
8.
go back to reference Mehrkhani F, Nasiri S, Donboli K, Meysamie A, Hedayat A (2009) Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Dis 11:157–161PubMedCrossRef Mehrkhani F, Nasiri S, Donboli K, Meysamie A, Hedayat A (2009) Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Dis 11:157–161PubMedCrossRef
9.
go back to reference Cho YB, Chun HK, Yun HR, et al. (2009) Histological grade predicts survival time associated with recurrence after resection for colorectal cancer. Hepatogastroenterology 56:1335–1340PubMed Cho YB, Chun HK, Yun HR, et al. (2009) Histological grade predicts survival time associated with recurrence after resection for colorectal cancer. Hepatogastroenterology 56:1335–1340PubMed
10.
go back to reference Rosai J, Ackerman LV (2011) Gastrointestinal tract—large bowel. In: Rosai J (ed) Rosai and Ackerman’s Surgical Pathology, 10th edn. Amsterdam: Elsevier, pp 762–768 Rosai J, Ackerman LV (2011) Gastrointestinal tract—large bowel. In: Rosai J (ed) Rosai and Ackerman’s Surgical Pathology, 10th edn. Amsterdam: Elsevier, pp 762–768
11.
go back to reference Sosna J, Morrin MM, Kruskal JB, et al. (2003) Colorectal neoplasms: role of intravenous contrast-enhanced CT colonography. Radiology 228:152–156PubMedCrossRef Sosna J, Morrin MM, Kruskal JB, et al. (2003) Colorectal neoplasms: role of intravenous contrast-enhanced CT colonography. Radiology 228:152–156PubMedCrossRef
12.
go back to reference International Union Against Cancer (UICC) (2002) Histopathological grading. In: Sobin LH, Wittekind C (eds) TNM classification of malignant tumor, 6th edn. New York: Wiley-Liss, p 13 International Union Against Cancer (UICC) (2002) Histopathological grading. In: Sobin LH, Wittekind C (eds) TNM classification of malignant tumor, 6th edn. New York: Wiley-Liss, p 13
13.
go back to reference Hamilton SR, Vogelstein B, Kudo S (2000) Carcinoma of the colon and rectum. In: Hamilton S, Aaltonen L (eds) World health organization classification of tumors-pathology and genetics of tumors of the digestive system. Lyon: IARC Press, pp 105–119 Hamilton SR, Vogelstein B, Kudo S (2000) Carcinoma of the colon and rectum. In: Hamilton S, Aaltonen L (eds) World health organization classification of tumors-pathology and genetics of tumors of the digestive system. Lyon: IARC Press, pp 105–119
14.
go back to reference Edge SB, Byrd DR, Compton CC, et al. (2010) Colon and rectum. In: Edge SB (ed) AJCC cancer staging manual, 7th edn. New York: Springer, pp 143–156 Edge SB, Byrd DR, Compton CC, et al. (2010) Colon and rectum. In: Edge SB (ed) AJCC cancer staging manual, 7th edn. New York: Springer, pp 143–156
15.
go back to reference George SM, Makinen MJ, Jernvall P, et al. (2000) Classification of advanced colorectal carcinomas by tumor edge morphology: evidence for different pathogenesis and significance of polypoid and nonpolypoid tumors. Cancer 89:1901–1909PubMedCrossRef George SM, Makinen MJ, Jernvall P, et al. (2000) Classification of advanced colorectal carcinomas by tumor edge morphology: evidence for different pathogenesis and significance of polypoid and nonpolypoid tumors. Cancer 89:1901–1909PubMedCrossRef
16.
go back to reference Cooper HS, Slemmer JR (1991) Surgical pathology of carcinoma of the colon and rectum. Semin Oncol 18:367–380PubMed Cooper HS, Slemmer JR (1991) Surgical pathology of carcinoma of the colon and rectum. Semin Oncol 18:367–380PubMed
18.
go back to reference Biffi R, Botteri E, Bertani E, et al. (2013) Factors predicting worse prognosis in patients affected by pT3 N0 colon cancer: long-term results of a monocentric series of 137 radically resected patients in a 5-year period. Int J Colorectal Dis 28:207–215PubMedCrossRef Biffi R, Botteri E, Bertani E, et al. (2013) Factors predicting worse prognosis in patients affected by pT3 N0 colon cancer: long-term results of a monocentric series of 137 radically resected patients in a 5-year period. Int J Colorectal Dis 28:207–215PubMedCrossRef
19.
go back to reference Weiser MR, Posner MC, Saltz LB (2013) Adenocarcinoma of the colon and rectum. In: Yeo CJ, Pemberton JH (eds) Shackelford’s surgery of the alimentary tract, 7th edn. Philadelphia: Elsevier Saunders, p 2066 Weiser MR, Posner MC, Saltz LB (2013) Adenocarcinoma of the colon and rectum. In: Yeo CJ, Pemberton JH (eds) Shackelford’s surgery of the alimentary tract, 7th edn. Philadelphia: Elsevier Saunders, p 2066
20.
go back to reference Foxtrot Collaborative Group (2012) Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol 13:1152–1160PubMedCentralPubMedCrossRef Foxtrot Collaborative Group (2012) Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol 13:1152–1160PubMedCentralPubMedCrossRef
21.
go back to reference Nørgaard A, Dam C, Jakobsen A, et al. (2014) Selection of colon cancer patients for neoadjuvant chemotherapy by preoperative CT scan. Scand J Gastroenterol 49:202–208PubMedCrossRef Nørgaard A, Dam C, Jakobsen A, et al. (2014) Selection of colon cancer patients for neoadjuvant chemotherapy by preoperative CT scan. Scand J Gastroenterol 49:202–208PubMedCrossRef
22.
go back to reference Masuda H, Abe Y, Takayama T (2005) Microsatellite instability in poorly differentiated colorectal adenocarcinoma, particularly in relation to two subtypes. Hepatogastroenterology 52:82–85PubMed Masuda H, Abe Y, Takayama T (2005) Microsatellite instability in poorly differentiated colorectal adenocarcinoma, particularly in relation to two subtypes. Hepatogastroenterology 52:82–85PubMed
23.
go back to reference De Sousa E, Melo F, Vermeulen L, Fessler E, Medema JP (2013) Cancer heterogeneity—a multifaceted view. EMBO Rep 14:686–695CrossRef De Sousa E, Melo F, Vermeulen L, Fessler E, Medema JP (2013) Cancer heterogeneity—a multifaceted view. EMBO Rep 14:686–695CrossRef
24.
go back to reference Furukawa H, Hara T, Taniguchi T (1992) Colorectal carcinoma evaluated by incremental dynamic CT: comparison of CT density, histology, and tumor size. Gastroenterol Jpn 27:334–340PubMed Furukawa H, Hara T, Taniguchi T (1992) Colorectal carcinoma evaluated by incremental dynamic CT: comparison of CT density, histology, and tumor size. Gastroenterol Jpn 27:334–340PubMed
25.
go back to reference Kim JW, Jeong YY, Chang NK, et al. (2012) Perfusion CT in colorectal cancer: comparison of perfusion parameters with tumor grade and microvessel density. Korean J Radiol 13(Suppl 1):S89PubMedCentralPubMedCrossRef Kim JW, Jeong YY, Chang NK, et al. (2012) Perfusion CT in colorectal cancer: comparison of perfusion parameters with tumor grade and microvessel density. Korean J Radiol 13(Suppl 1):S89PubMedCentralPubMedCrossRef
Metadata
Title
Differentiation of poorly differentiated colorectal adenocarcinomas from well- or moderately differentiated colorectal adenocarcinomas at contrast-enhanced multidetector CT
Authors
Ji Eun Kim
Jeong Min Lee
Jee Hyun Baek
Sung Kyung Moon
Se Hyung Kim
Joon Koo Han
Byung Ihn Choi
Publication date
01-01-2015
Publisher
Springer US
Published in
Abdominal Radiology / Issue 1/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-014-0176-z

Other articles of this Issue 1/2015

Abdominal Radiology 1/2015 Go to the issue

Classics in Abdominal Imaging

Rigler’s Triad

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine